{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:31:01Z","timestamp":1787729461824,"version":"build-2784847793"},"reference-count":37,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Policy, Politics, &amp; Nursing Practice"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:p>Xylazine, a veterinary sedative, has emerged as a concerning element in the landscape of substance use in the United States. This integrative review synthesizes evidence from a systematic examination of 14 selected studies conducted between 2008 and 2023. The primary objective is to comprehensively understand the epidemiology and prevalence of xylazine use, particularly its involvement in drug-related deaths, regional variations, national impact, co-occurrence with opioids, and challenges associated with detection and intervention. The results underscore stark regional disparities in xylazine prevalence. West Virginia and Miami-Dade County have experienced alarming surges in xylazine-involved drug-related deaths. Nationally, its influence extends beyond regional boundaries, predominantly affecting white males in the Northeast. The co-occurrence of xylazine with opioids, especially fentanyl and heroin, significantly amplifies the risks of fatal overdoses. Detecting xylazine presents formidable challenges due to its frequent presence alongside other substances, necessitating enhanced surveillance and more effective detection methods. User perspectives emerge as pivotal, emphasizing the importance of user-informed harm reduction strategies. In conclusion, this review has significant policy implications. Tailored, region-specific strategies are imperative to address the diverse prevalence of xylazine use. A nationwide response is indispensable, prioritizing harm reduction initiatives, enhanced detection methods, and active user engagement. The multifaceted nature of the xylazine issue requires comprehensive approaches to mitigate its profound risks effectively. Policymakers are urged to consider regional disparities and the co-occurrence of xylazine with opioids when crafting targeted interventions. Immediate, user-informed harm reduction is vital to address the evolving landscape of xylazine use in the United States.<\/jats:p>","DOI":"10.1177\/15271544241268386","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T02:47:54Z","timestamp":1723085274000},"page":"241-253","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":16,"title":["Xylazine in the Unregulated Drug Market: An Integrative Review of Its Prevalence, Health Impacts, and Detection and Intervention Challenges in the United States"],"prefix":"10.1177","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3249-9101","authenticated-orcid":false,"given":"Evans F.","family":"Kyei","sequence":"first","affiliation":[{"name":"Center for Substance Use Research and Related Conditions, The University of Alabama, Tuscaloosa, AL, USA"},{"name":"Department of Nursing, Manning College of Nursing and Health Sciences, University of Massachusetts Boston, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7891-9513","authenticated-orcid":false,"given":"Grace K.","family":"Kyei","sequence":"additional","affiliation":[{"name":"Department of Nursing, Manning College of Nursing and Health Sciences, University of Massachusetts Boston, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rockson","family":"Ansong","sequence":"additional","affiliation":[{"name":"Department of Nursing, Manning College of Nursing and Health Sciences, University of Massachusetts Boston, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles K.","family":"Boakye","sequence":"additional","affiliation":[{"name":"Institute of Global Health, Geneva Graduate Institute, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Asamoah","sequence":"additional","affiliation":[{"name":"Department of Nursing, Manning College of Nursing and Health Sciences, University of Massachusetts Boston, Boston, MA, USA"},{"name":"The Emergency Department, The Miriam Hospital, Providence, RI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"bibr1-15271544241268386","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2022.306881"},{"issue":"3","key":"bibr2-15271544241268386","volume":"15","author":"Ayub S.","year":"2023","journal-title":"Cureus"},{"key":"bibr3-15271544241268386","author":"Bedard M. L.","year":"2023","journal-title":"BioRxiv"},{"key":"bibr4-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00546-9"},{"key":"bibr5-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.110833"},{"key":"bibr6-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-058684"},{"key":"bibr7-15271544241268386","doi-asserted-by":"publisher","DOI":"10.7326\/M23-2001"},{"key":"bibr8-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000955"},{"key":"bibr9-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109380"},{"key":"bibr10-15271544241268386","first-page":"1","volume":"00","author":"Holt A. C.","year":"2023","journal-title":"Journal of Addiction Medicine, Publish Ah"},{"key":"bibr11-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1136\/injuryprev-2020-043968"},{"key":"bibr12-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkac049"},{"issue":"37","key":"bibr13-15271544241268386","first-page":"2019","volume":"70","author":"Kariisa M.","year":"2021","journal-title":"Morbidity Mortality Weekly Report 2021"},{"key":"bibr14-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1037\/pha0000670"},{"key":"bibr15-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2021.07.010"},{"key":"bibr16-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1177\/15271544231164323"},{"key":"bibr17-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmn.2024.03.017"},{"key":"bibr18-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2009.02.019"},{"key":"bibr19-15271544241268386","volume-title":"Subcutaneous Lesions and Systemic Infections: A Scoping Review of the Clinical Implications of Illicit Xylazine Use","author":"Maiga F. A.","year":"2023"},{"key":"bibr20-15271544241268386","volume-title":"Xylazine-Induced Skin Ulcers in a Person Who Injects Drugs in Philadelphia","author":"Malayala S. V.","year":"2022"},{"key":"bibr21-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001245"},{"key":"bibr22-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107547"},{"key":"bibr23-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1097\/PAF.0000000000000622"},{"key":"bibr24-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01626-4"},{"issue":"6","key":"bibr25-15271544241268386","volume":"15","author":"Pergolizzi J.","year":"2023","journal-title":"Cureus"},{"key":"bibr26-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1111\/1556-4029.15375"},{"key":"bibr27-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104154"},{"key":"bibr28-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2022.100074"},{"key":"bibr29-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13365"},{"key":"bibr30-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001216"},{"key":"bibr31-15271544241268386","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:129519"},{"key":"bibr32-15271544241268386","doi-asserted-by":"publisher","DOI":"10.47836\/\/mjmhs18.4.26"},{"key":"bibr33-15271544241268386","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7037a5"},{"key":"bibr34-15271544241268386","first-page":"112","volume":"128","author":"Thomas McLellan A.","year":"2017","journal-title":"Transactions of the American Clinical and Climatological Association"},{"key":"bibr35-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1186\/1747-597X-6-7"},{"key":"bibr36-15271544241268386","doi-asserted-by":"crossref","unstructured":"Wahbi R., Dye D., Goodman-Meza D., Shover C., Friedman J., Montero F., Bourgois P. (2022). Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis\n                      .\n                      https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109380","DOI":"10.1016\/j.drugalcdep.2022.109380"},{"key":"bibr37-15271544241268386","doi-asserted-by":"publisher","DOI":"10.1111\/j.1556-4029.2007.00648.x"}],"container-title":["Policy, Politics, &amp; Nursing Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15271544241268386","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15271544241268386","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15271544241268386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T05:49:23Z","timestamp":1777700963000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15271544241268386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1177\/15271544241268386"],"URL":"https:\/\/doi.org\/10.1177\/15271544241268386","relation":{},"ISSN":["1527-1544","1552-7468"],"issn-type":[{"value":"1527-1544","type":"print"},{"value":"1552-7468","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]}}}